Events

Now in its 10th year, IBC's Single-Use Applications for Biopharmaceutical Manufacturing, taking place June 3-5, 2013 in Durham, North Carolina provides you with the updated evolutionary pathway for Single-Use applications. This program will discuss the future of Single-Use applications, the next frontiers, and recognize the contributions by industry leaders and companies in this developing field.

Now in its 4th year, IBC's Vaccine Development & Production Summit, to take place June 3-5, 2013 in Durham, North Carolina continues to look at ways to improve yield and reduce cost in vaccine production - 2 of the biggest concerns for vaccine manufacturers.

IBC Life Sciences' Bioprocess Training Academy course are two-day training sessions that allow you to increase job skills, develop solutions, gain industry insight and expand your network. May: San Diego, CA; June: Cambridge, MA.

This course provides fundamental understanding of biopharmaceutical manufacturing. It consists of an initial overview of biopharmaceuticals and its industry followed by detailed explanation on the unit operations, facilities, process development and quality considerations for biomanufacturing.

This course focuses on the design principles of modern purification processes for the manufacturing of biopharmaceutical products. Learn the fundamentals of critical enabling technologies such as chromatography and filtration.

This course provides a comprehensive discussion of the scientific principles of microbial fermentation and mammalian cell culture bioprocessing as pertinent to the development of pilot and large scale manufacturing of biopharmaceutical products.

This course offers a panoramic review of analytical method development and validation for therapeutic proteins, including antibodies and enzymes.

IBC's Applications for Enzyme Technologies conference focuses on exciting new technical developments and successes in the now-burgeoning enzyme market.

IBC's Next Generation Protein Therapeutics Summit is the only conference on the market which consistently brings together every leading company and academic scientist working in alternative scaffold and next-generation protein therapeutic development.

IBC has taken the lead to bring all the industry experts together to give you the answers you need to move ahead your discovery, design or development program. This is the first program to combine coverage of ADCs and other bioconjugates so you can expand your knowledge base and move your programs efficiently ahead from bench to bedside.